Now accepting Telehealth appointments. Schedule a virtual visit.

Pets Improving Mental Health

There are numerous physical and mental health benefits that come along with ownning a companion animal. Pets, such as dogs and cats, are able to help reduce stress, anxiety, and depression along with easing any loneliness individuals may have. They also encourage their owners to exercise which aids in improving the cardiovascular health. In addition, children can grow up more secure and active through caring for animals. 

Studies have shown that being a pet owner can help individuals become less likely to suffer from depression than those without pets. It can also help to lower blood pressure in stressful situations, elevate levels of serotonin and dopamine, and lower triglyceride and cholesterol levels, which are indicators of heart disease. 

Also, pets can help individuals live a healthier lifestyle and adjust changes to improve their overall wellbeing. This is crucial since adapting to a healthy lifestyle plays a role in easing symptoms of depression, anxiety, stress, bipolar disorder, and PTSD. For example, being a pet owner can help with increasing exercise, providing companionship, reducing anxiety, and adding structure and/or a routine to your day. Therefore, through this, it demonstrates the mutual benefits between a pet and their owner. 

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).